Mid career · publishing since 2011Rising activity
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentPARP inhibition in cancer therapyCancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers
Publications
186
Citations
1,967
Est. group size
~41
Recurring co-author estimate
Active years
16
Publishing since 2011
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 1,967p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 28.8p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~22 · 8% small-team papers (≤3 authors) · across 11 venues
Publication cadence
Publications per year over the last 10 years — averaging 28.8/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Figure 1 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 4 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 7 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Figure 3 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 5 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Table 4 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Figure 2 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Table 1 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Figure 5 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 6 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Figure 4 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 1 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Supplementary Table 8 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Table 3 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
- Table 2 from Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study
2026
Publishes in
- Journal of Clinical Oncology×29
- The Journal of Urology×7
- Cancer Research×7
- Annals of Oncology×4
- JCO Precision Oncology×3
Similar researchers
By research-topic overlap
- Scott A. Tomlins
Medicine · University of Michigan
- Udit Singhal
Medicine · University of Michigan
- Lakshmi P. Kunju
Medicine · University of Michigan
- Charles J. Ryan
Medicine · University of Michigan
- Neil Vaishampayan
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile